Latham & Watkins Advises on Financing to Support Enovis’ Acquisition of LimaCorporate S.P.A.

Enovis™ Corporation (NYSE: ENOV, Enovis or the Company), an innovation-driven, medical technology growth company, has announced a definitive agreement to acquire LimaCorporate S.p.A. (Lima), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions. The acquisition has an enterprise value of approximately €800 million, consisting of a €700 million cash payment at closing and €100 million in shares of Enovis common stock.

Latham & Watkins LLP represented the financing sources in the transaction with a banking team led by partners Zulf Bokhari and Jesse Sheff and counsel Andrea Keller, with associates Katherine Page, Michael Waldman, Rob Rogowski, Michael Harris, and Kate Bell, as well as a capital markets team led by partners Stelios Saffos and Peter Sluka, with associate Hana Nah. Advice was also provided on intellectual property matters by partners Jeffrey Tochner and James Ktsanes; on benefits and compensation matters by partner Benjamin Rosemergy, with associate Kevin Matheny; and on intellectual property and data privacy matters by partner Michelle Gross, with associates Ryan Sanders and Kiara Vaughn.